Search Results 661-670 of 24211 for In situ

1. A Study To Evaluate The Onset Of Effect And Time Course Of Change In Lung Function With Benralizumab In Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation - Mayo Clinic

   ... In Lung Function With Benralizumab In Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation ... situ carcinoma of the cervix are eligible provided ...

2. Study to Investigate the Safety, Pharmacokinetic Profiles and the Efficacy of Tinostamustine, a First-in-Class Alkylating Histone Deacetylase Inhibition Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   ... in situ cervical cancer that has undergone potentially curative therapy; Pregnant or breast feeding females; New York Heart Association (NYHA) stage III/IV ...

3. Clinical trials - Oncology (Medical)

   ... in treating patients with HER2 expressing ductal carcinoma in situ. H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of ...

4. Study of Pembrolizumab Combined with Decitabine and Pralatrexate in Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma - Mayo Clinic

   Exceptions include basal cell carcinoma of the skin or squamous cell carcinoma of the skin that has undergone potentially curative therapy or in situ cervical ...

5. A Study of Poziotinib in Patients with NSCLC With EGFR or HER2 Exon 20 Insertion Mutation - Mayo Clinic

   ... in situ of the cervix or breast without need of treatment. Patient is confirmed to have clinically significant or recent acute gastrointestinal disease ...

6. Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine - Mayo Clinic

   Any active malignancy within the past year, except basal cell or squamous cell skin cancer or carcinoma in situ of the cervix or breast. Uncontrolled ...

7. Breast cancer - Doctors and departments - Mayo Clinic

   ... situ, Ductal carcinoma in situ, Invasive lobular carcinoma, Paget's ... Mayo Clinic in Rochester, Minnesota, Mayo Clinic in Jacksonville, Florida ...

8. IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma - Mayo Clinic

   Patients with nonmelanoma skin cancer or carcinoma in situ of any type are not excluded if they have undergone complete resection; Inability or unwillingness ...

9. Elotuzumab In Immunoglobulin G4-Related Disease (IgG4-RD) - Mayo Clinic

   Malignancy within 5 years (except successfully treated in situ cervical cancer, resected squamous cell or basal cell carcinoma of the skin.) the following ...

10. Oncology (Medical) - Clinical trials

    ... in treating patients with HER2 expressing ductal carcinoma in situ. H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of ...